Caden Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Live Nation Entertainment
LYV
|
+$27.4M |
| 2 |
UnitedHealth
UNH
|
+$23.3M |
| 3 |
Steris
STE
|
+$5.8M |
| 4 |
Crown Castle
CCI
|
+$4.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
International Flavors & Fragrances
IFF
|
+$11.6M |
| 2 |
GE Aerospace
GE
|
+$11.3M |
| 3 |
PG&E
PCG
|
+$10.2M |
| 4 |
Danaher
DHR
|
+$7.43M |
| 5 |
Becton Dickinson
BDX
|
+$6.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.28% |
| 2 | Real Estate | 13.73% |
| 3 | Materials | 11.14% |
| 4 | Consumer Discretionary | 10.19% |
| 5 | Communication Services | 9.82% |
Similar funds
Caden Capital Partners's Q2 2024 Portfolio in Review
As of Q2 2024, Caden Capital Partners held 12 positions worth $277M, up 1.5% from $272M the previous quarter. Its ten largest holdings account for 95% of the portfolio.
Caden Capital Partners deployed $8.75M of net new capital in Q2 2024, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was Live Nation Entertainment: 289,591 shares worth $27.1M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 35% a quarter earlier, followed by Real Estate and Materials.
On the sell side, the largest reduction was International Flavors & Fragrances, an estimated $11.6M trimmed.
- Caden Capital Partners's largest Q2 2024 buy was Live Nation Entertainment: 289,591 shares worth $27.1M.
- Caden Capital Partners added most to Steris in Q2 2024, an estimated $5.8M increase.
- Caden Capital Partners's biggest Q2 2024 reduction was International Flavors & Fragrances, cutting an estimated $11.6M.
- Caden Capital Partners fully exited GE Aerospace in Q2 2024, selling an estimated $11.3M.
- Caden Capital Partners's ten largest holdings make up 95% of its $277M portfolio in Q2 2024.
- Caden Capital Partners opened 2 new positions and closed 1 in Q2 2024.
- Caden Capital Partners's portfolio value rose 1.5% quarter-over-quarter to $277M.
Based on Caden Capital Partners's 13F filing for Q2 2024, filed 14 Aug 2024.